日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Using Next Generation Chemiluminescent Probes to Improve the Plasmodium falciparum in vitro Parasite Reduction Ratio (PRR) Assay

利用新一代化学发光探针改进恶性疟原虫体外寄生虫减少率(PRR)检测

Hellingman, Angela; Göttle, Nele Lara; Walz, Annabelle; Brancucci, Nicolas Michel Beat; Wittlin, Sergio; Mäser, Pascal; Rottmann, Matthias

Integrative preclinical strategy for pharmacokinetic profiling and candidate selection of 3-hydroxypropanamidines: a promising antimalarial class

3-羟基丙脒类药物(一种有前景的抗疟药)的药代动力学分析和候选药物筛选的综合临床前策略

Moritz, Alena; Hirn-Derksen, Bastian; Klein, Saskia; Held, Jana; Wittlin, Sergio; Rottmann, Matthias; Kurz, Thomas; Burckhardt, Bjoern B

A Novel Antimalarial Agent that Inhibits Protein Synthesis in Plasmodium falciparum

一种新型抗疟药,可抑制恶性疟原虫的蛋白质合成

Bravo, Patricia; Diamanti, Eleonora; Hamed, Mostafa M; Bizzarri, Lorenzo; Wiedemar, Natalie; Passecker, Armin; Brancucci, Nicolas M B; Albisetti, Anna; Gumpp, Christin; Illarionov, Boris; Fischer, Markus; Witschel, Matthias; Schehl, Tobias; Hahne, Hannes; Mäser, Pascal; Rottmann, Matthias; Hirsch, Anna K H

An all-in-one pipeline for the in vitro discovery and in vivo testing of Plasmodium falciparum malaria transmission blocking drugs.

用于体外发现和体内测试恶性疟原虫疟疾传播阻断药物的一体化流程

Brancucci Nicolas M B, Gumpp Christin, van Gemert Geert-Jan, Yu Xiao, Passecker Armin, Nardella Flore, Thommen Basil T, Chambon Marc, Turcatti Gerardo, Halby Ludovic, Blasco Benjamin, Duffey Maëlle, Arimondo Paola B, Bousema Teun, Scherf Artur, Leroy Didier, Kooij Taco W A, Rottmann Matthias, Voss Till S

A Phase II Multicenter Trial of Trabectedin in Combination with Olaparib in Patients with Advanced Unresectable or Metastatic Sarcoma.

一项 II 期多中心试验,评估曲贝替定联合奥拉帕尼治疗晚期不可切除或转移性肉瘤患者的疗效

Siontis Brittany L, Rice John D, Schuetze Scott M, Rottmann Douglas, Angeles Christina V, Fox Amanda K, Zyczynski Laurie E, Hayek Salim, Robinson Steven I, Okuno Scott H, Ho Thanh P, Chugh Rashmi

Positive Charge in an Antimalarial Compound Unlocks Broad-Spectrum Antibacterial Activity

抗疟化合物中的正电荷可释放广谱抗菌活性

Braun-Cornejo, Maria; Platteschorre, Mitchell; de Vries, Vincent; Bravo, Patricia; Sonawane, Vidhisha; Hamed, Mostafa M; Haupenthal, Jörg; Reiling, Norbert; Rottmann, Matthias; Piet, Dennis; Maas, Peter; Diamanti, Eleonora; Hirsch, Anna K H

Pharmacokinetics, Excretion, and Organ Distribution of the Novel Gadolinium-Based MRI Contrast Agent Gadoquatrane in Female Cynomolgus Monkeys

新型钆基MRI造影剂Gadoquatrane在雌性食蟹猴体内的药代动力学、排泄和器官分布

Guenther, Clemens; Frenzel, Thomas; Rottmann, Antje; Lohrke, Jessica; Janssen, Wiebke

Structure-Activity Relationships of 3-Hydroxypropanamidines (HPAs) with Potent In Vivo Antimalarial Activity

3-羟基丙脒类化合物(HPAs)的构效关系及其强效的体内抗疟活性

Klein, Saskia; Moritz, Alena; Pessanha de Carvalho, Lais; Knaab, Tanja C; Lungerich, Beate; Meyer, Lukas; Sandström, Jona; Thibaud, Jessica L; de Villiers, Katherine A; Fidock, David A; Wittlin, Sergio; Rottmann, Matthias; Held, Jana; Burckhardt, Bjoern B; Kurz, Thomas

Analysis of patient characteristics and safety of insulin glargine U300 use in 21 359 patients with type-2 diabetes and chronic kidney disease: DPV registry study

对 21359 例合并慢性肾脏病的 2 型糖尿病患者使用甘精胰岛素 U300 的患者特征和安全性进行分析:DPV 注册研究

Vijayan, Anjaly; Lanzinger, Stefanie; Forestier, Nicole; Hess, Gregor; Rottmann, Marcus; Wosch, Frank J; Seufert, Jochen; Holl, Reinhard W; Bramlage, Peter

Pulmonary tuberculosis in a rural hospital in Sierra Leone

塞拉利昂一家乡村医院的肺结核病例

Rottmann, Henning; Olaru, Ioana D; Kanu, Emmanuel Marx; Theiler, Tom; Kargbo, Islam M; Kelling, Emil; Kalkman, Laura; Grobusch, Martin P; Schaumburg, Frieder